miR-320 |
Major depression |
miR-320 family may be important as a peripheral biomarker |
|
Autism |
miR-320 was dysregulated in lymphoblastoid cell lines of autism patients |
miR-106 |
Major depression |
miR-106a-5p levels was higher in depressed patients |
|
Schizophrenia |
miR-106b-5p levels was higher in schizophrenia patients |
|
Attention deficit hyperactivity disorder |
Lower miR-106b-5p levels were determined in the control group |
|
Autism |
miR-106-5p showed higher expression in autism |
miR-34 |
Major depression |
miR-34b-5p and miR-34c-5p levels in peripheral blood leukocytes were closely related to suicide idea and cognitive function |
|
Schizophrenia |
miR-34 were presented as peripheral biomarkers |
|
Bipolar disorder |
miR34-a may be critical for bipolar disorder in terms of neurodevelopment |
|
Alzheimer’s disease |
miR-34a was observed to be decreased in plasma and cerebrospinal fluid according to the control group |
miR-223 |
Major depression |
miR-223-3p levels were reported to be significantly higher in patients than in controls |
|
Posttraumatic stress disorder |
miR-223 could be a potential biomarker |
miR-107 |
Amnestic mild cognitive impairment |
miR107 expressions in plasma had a high capability to distinguish individuals with amnestic mild cognitive impairment from healthy controls |
|
Major depression |
Positive correlation between N1, P2latency of P300 and miR-107 in depressed patients |
miR-134 |
Mild cognitive impairment |
miRNA biomarker pairs successfully detected MCI in most of the patients at asymptomatic stage |
|
Bipolar disorder |
Decreased miR-134 level was directly associated with bipolar disorder |